This vicious cycle of microbiota-induced ferroptosis ultimately leads to intestinal barrier disruption, pathogen translocation, and sustained amplification of the inflammatory cascade
Certain health conditions, such as pernicious anemia or specific gastrointestinal disorders that affect B12 absorption, may require even longer-term or lifelong monthly injections
TB-500 human tolerability studies report mild adverse events at doses up to 1,260 mg [5] [11]
Use is strictly research-only
Gut symptoms often show first improvements within 2 to 4 weeks, while tendon and ligament changes usually begin around 3 to 4 weeks after a protocol that had stalled in physical therapy
Bottom Line Current research indicates that oral BPC-157 may be more suitable for gastrointestinal support, while injectable BPC-157 has been the primary focus in studies exploring recovery beyond the digestive tract